Clinical Trials Directory

Trials / Completed

CompletedNCT04976439

Patogenic Mutation in 5 Genes

Genomic Landscape of APC, KRAS, TP53, PIK3CA, and MLH1 in Colorectal

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Dr Cipto Mangunkusumo General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a pathogenic mutation profile of colorectal patients specifically in 5 genes, i.e. APC, TP53, PIK3CA, KRAS, and MLH1. Single nucleotide variants identified were synchronized with patients' characteristics.

Conditions

Interventions

TypeNameDescription
OTHERco-occuring mutationAPC, TP53, PIK3CA, KRAS APC, TP53, PIK3CA, MLH1 APC, TP53, PIK3CA, KRAS, and MLH1 APC, TP53, PIK3CA

Timeline

Start date
2021-05-01
Primary completion
2021-06-10
Completion
2021-06-14
First posted
2021-07-26
Last updated
2021-07-26

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04976439. Inclusion in this directory is not an endorsement.

Patogenic Mutation in 5 Genes (NCT04976439) · Clinical Trials Directory